TherapeuticsMD, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10QSB
144
25
3
3/A
4
4/A
424B2
424B3
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
AW
CERTNAS
CERTNYS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
POSASR
PRE 14A
PRE 14C
PREM14A
PRER14A
PRER14C
S-1
S-3
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-005779 | Jan 21, 2026 | Jan 15, 2026 |
| 4 | — | 0000905148-25-004488 | Dec 29, 2025 | Dec 23, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-122240 | Dec 16, 2025 | Dec 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-109479 | Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-109381 | Nov 12, 2025 | Sep 30, 2025 |
| 4 | — | 0000905148-25-003785 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | — | 0000905148-25-003784 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | — | 0000905148-25-003783 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | — | 0000905148-25-003782 | Nov 5, 2025 | Nov 3, 2025 |
| ARS | ARS | 0001213900-25-105185 | Nov 3, 2025 | Dec 31, 2024 |
| DEFA14A | PROXY STATEMENT | 0001213900-25-105184 | Nov 3, 2025 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-25-105183 | Nov 3, 2025 | Dec 15, 2025 |
| PRE 14A | PROXY STATEMENT | 0001213900-25-102166 | Oct 24, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-075003 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-074975 | Aug 12, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-042697 | May 13, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-042663 | May 13, 2025 | — |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-25-037713 | Apr 30, 2025 | Dec 31, 2024 |
| 4 | — | 0000905148-25-001216 | Apr 15, 2025 | Apr 14, 2025 |
| 4 | — | 0000905148-25-001215 | Apr 15, 2025 | Apr 14, 2025 |
| 4 | — | 0000905148-25-001190 | Apr 10, 2025 | Apr 9, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-030089 | Apr 9, 2025 | Apr 8, 2025 |
| 10-K | ANNUAL REPORT | 0001013762-25-003442 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001013762-25-003407 | Mar 27, 2025 | — |
| 4 | — | 0000905148-25-000740 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0000905148-25-000739 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0000905148-25-000738 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0000905148-25-000737 | Feb 20, 2025 | Feb 18, 2025 |
| SCHEDULE 13G | — | 0001600136-25-000003 | Feb 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-24-106095 | Dec 5, 2024 | — |
| SC 13G | — | 0001600136-24-000007 | Nov 12, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-096811 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-096804 | Nov 12, 2024 | — |
| ARS | FORM ARS | 0001213900-24-090852 | Oct 25, 2024 | Dec 31, 2023 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-090850 | Oct 25, 2024 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-24-090849 | Oct 25, 2024 | Dec 5, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-080719 | Sep 20, 2024 | — |
| 4 | — | 0000905148-24-002363 | Aug 26, 2024 | Aug 22, 2024 |
| 4 | — | 0000905148-24-002340 | Aug 23, 2024 | Aug 21, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-067771 | Aug 12, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-067670 | Aug 12, 2024 | — |
| AW | AMENDMENT WITHDRAWAL REQUEST | 0001213900-24-052954 | Jun 14, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-041738 | May 10, 2024 | Mar 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-041735 | May 10, 2024 | — |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-24-037258 | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | ANNUAL REPORT | 0001213900-24-028003 | Mar 29, 2024 | Dec 31, 2023 |
| 8-K | CURRENT REPORT | 0001213900-24-027998 | Mar 29, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-057725 | Dec 7, 2023 | Dec 5, 2023 |
| 144 | — | 0001974078-23-000264 | Dec 6, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-119332 | Nov 17, 2023 | — |